Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (The MINIMISE STEMI Trial): Rationale and Study Design

• Main Authors: Bulluck H., Frohlich G.M., Mohdnazri S., Gamma R.A., Davies J.R., Clesham G.J., Sayer J.W., Aggarwal R.K., Tang K.H., Kelly P.A., Jagathesan R., Kabir A., Robinson N.M., Sirker A., Mathur A., Blackman D.J., Ariti C., Krishnamurthy A., White S.K., Meier P., Moon J.C., Greenwood J.P., Derek J. Hausenloy
• 其他作者: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• 格式: Article
• 出版: John Wiley and Sons Inc. 2016
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/123349
• 機構: National University of Singapore

Clinical Cardiology